ArticleAnnals of hematology2023

Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploidentical stem cell transplantation.

Shigeki Kosugi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.